Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$36.62 - $51.69 $46,177 - $65,181
-1,261 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$41.56 - $59.88 $4,862 - $7,005
-117 Reduced 8.49%
1,261 $61,000
Q4 2020

Feb 03, 2021

SELL
$36.08 - $56.47 $4,798 - $7,510
-133 Reduced 8.8%
1,378 $74,000
Q3 2020

Nov 06, 2020

SELL
$33.26 - $40.48 $19,024 - $23,154
-572 Reduced 27.46%
1,511 $56,000
Q2 2020

Jul 17, 2020

BUY
$24.21 - $31.02 $26,219 - $33,594
1,083 Added 108.3%
2,083 $65,000
Q3 2019

Nov 05, 2019

BUY
$19.12 - $26.24 $19,120 - $26,240
1,000 New
1,000 $19,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.23B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Prime Capital Investment Advisors, LLC Portfolio

Follow Prime Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.